The neuroophtalmologist at Mayo Clinic detailed improvements in prescribing methods for NMOSD treatments and the conversations surrounding reversing neurodegeneration. [WATCH TIME: 3 minutes]
John Chen, MD, PhD
Advertisement
Articles by John Chen, MD, PhD
The neuroophthalmologist at Mayo Clinic discussed the current understanding of optic neuritis in neuromyelitis optica and the ways clinicians are working to improve recovery. [WATCH TIME: 4 minutes]
The neuroophthalmologist at mayo clinic provided context on the importance of raising awareness for NMOSD and the signs that precede clinical events. [WATCH TIME: 3 minutes]
Advertisement
Latest Updated Articles
Building a Greater Understanding for NMOSD Treatments, Neurodegeneration: John Chen, MD, PhDPublished: April 5th 2023 | Updated:
Improvements in Awareness of NMOSD, Optic Neuritis: John Chen, MD, PhDPublished: March 28th 2023 | Updated:
Improving Detection, Recovery of Optic Neuritis in NMOSD: John Chen, MD, PhDPublished: March 30th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 MG0020 Trial Highlights Success of Self-Administered Rozanolixizumab for Generalized Myasthenia Gravis
2
Efgartigimod Treatment for CIDP Leads to Increased Spending, Study Shows
3
Subcutaneous Efgartigimod Shows Efficacy in Phase 2 ALKIVIA, Phase 3 ADAPT SERON Trials
4
Open-Label Extension Highlights Continued Therapeutic Benefit of Nipocalimab in Patients Transitioning From Placebo
5
